Overview
Pulmonary agenesis is a rare congenital malformation characterized by the complete absence of one or both lungs, including the bronchus, pulmonary vasculature, and lung parenchyma. It is also referred to as lung agenesis. This condition results from a failure of the lung bud to develop during early embryonic life, typically around the fourth to fifth week of gestation. Pulmonary agenesis may be unilateral (affecting one lung) or bilateral (affecting both lungs). Bilateral pulmonary agenesis is incompatible with life. Unilateral pulmonary agenesis, while more survivable, can still present with significant morbidity depending on associated anomalies and the degree of compensatory growth of the remaining lung. Unilateral pulmonary agenesis primarily affects the respiratory system but may also be associated with congenital anomalies involving the cardiovascular, gastrointestinal, genitourinary, and musculoskeletal systems. Key clinical features include respiratory distress, recurrent respiratory infections, reduced exercise tolerance, and mediastinal shift toward the affected side. Some patients may remain relatively asymptomatic if the contralateral lung undergoes adequate compensatory hyperplasia. The condition is more commonly reported on the left side, and right-sided agenesis tends to carry a worse prognosis due to greater mediastinal shift and potential compression of the airways and great vessels. Diagnosis is typically made through imaging studies including chest X-ray, CT scan, and bronchoscopy, which confirm the absence of the lung and its bronchus. Prenatal diagnosis via ultrasound or fetal MRI is also possible. There is no curative treatment for pulmonary agenesis. Management is supportive and focuses on preventing and treating respiratory infections, managing associated anomalies, and monitoring respiratory function. In some cases, surgical intervention may be needed to address airway compression or cardiovascular complications. Long-term follow-up with a multidisciplinary team including pulmonologists, cardiologists, and surgeons is recommended.
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Pulmonary agenesis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pulmonary agenesis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pulmonary agenesis.
Community
No community posts yet. Be the first to share your experience with Pulmonary agenesis.
Start the conversation →Latest news about Pulmonary agenesis
No recent news articles for Pulmonary agenesis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pulmonary agenesis
What is Pulmonary agenesis?
Pulmonary agenesis is a rare congenital malformation characterized by the complete absence of one or both lungs, including the bronchus, pulmonary vasculature, and lung parenchyma. It is also referred to as lung agenesis. This condition results from a failure of the lung bud to develop during early embryonic life, typically around the fourth to fifth week of gestation. Pulmonary agenesis may be unilateral (affecting one lung) or bilateral (affecting both lungs). Bilateral pulmonary agenesis is incompatible with life. Unilateral pulmonary agenesis, while more survivable, can still present with
How is Pulmonary agenesis inherited?
Pulmonary agenesis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pulmonary agenesis typically begin?
Typical onset of Pulmonary agenesis is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Pulmonary agenesis?
5 specialists and care centers treating Pulmonary agenesis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.